Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Dry Static Apnoea for Recovery From Acute Laboratory Stress in Trained Breath-Hold Divers

16 de novembro de 2026 atualizado por: DeAsís-Fernández, Francisco, Universidad Rey Juan Carlos

Dry Static Apnoea as a Stress-Recovery Strategy: Salivary Cortisol and Heart Rate Variability After Acute Laboratory Stress in Trained Breath-Hold Divers. A Randomized Controlled Trial

This exploratory randomized controlled trial will test whether a short session of dry static apnoea (voluntary breath-holding while lying down, out of the water) helps trained breath-hold divers recover faster from a brief, standardized laboratory stressor than resting for the same amount of time.

Twenty-eight licensed breath-hold divers will attend a single afternoon session of about 85 minutes. All participants first complete the Maastricht Acute Stress Test (alternating immersion of one hand in cold water at about 2 °C with mental arithmetic and negative feedback). They are then randomly assigned to one of two 24-minute conditions: four supervised dry static apnoeas at 50% of their personal best (maximum 3 minutes each), or lying at rest while listening to a neutral informative audio. Both groups then rest until 60 minutes after the start of the stressor.

The main outcome is salivary cortisol 60 minutes after the start of the stressor. Heart rate, heart rate variability, blood pressure, state anxiety and perceived stress will also be compared between groups.

Visão geral do estudo

Descrição detalhada

Background. Acute stress activates the hypothalamic-pituitary-adrenal axis, which releases cortisol, and the autonomic nervous system, which raises heart rate and reduces vagal tone. For health, how quickly these responses return to baseline matters as much as their magnitude. Slow, controlled breathing increases vagal modulation and is associated with lower anxiety. Voluntary apnoea shares conscious breathing control and additionally triggers a vagally mediated bradycardia (the diving response), which is also present in dry apnoea. Breath-hold divers often report feeling calmer after training, but this has not been tested with objective markers. To avoid the floor effect of afternoon cortisol, a standardized stressor is applied first and the trial then tests whether apnoea accelerates recovery compared with rest. Trained breath-hold divers are studied because they master the technique and do not find it aversive.

Design. Exploratory, two-arm, parallel-group randomized controlled trial with a blinded outcome assessor. Randomization in blocks of 4, stratified by sex. The outcome assessor is unaware of group allocation; the principal investigator delivers the intervention. Sessions take place in the afternoon (arrival between 15:30 and 17:00) to control for the circadian rhythm of cortisol, at the Faculty of Health Sciences, Alcorcón Campus, Universidad Rey Juan Carlos (Madrid, Spain).

Session (about 85 minutes). Baseline rest and recordings; Maastricht Acute Stress Test (5 minutes of instructions and 10 minutes alternating hand immersion in water at about 2 °C with mental arithmetic aloud and negative feedback); 24-minute intervention; rest until 60 minutes after stressor onset; final debriefing.

Interventions. Experimental group: 4 dry static apnoeas in the supine position at 50% of personal best (maximum 3 minutes), in 5-minute cycles with at least 2 minutes of free breathing between apnoeas, under continuous supervision. Hyperventilation and lung packing are not allowed. Control group: supine rest for the same duration while listening to a neutral informative audio, previously validated with the Self-Assessment Manikin.

Measurements. Four passive-drool saliva samples (S1 at -7, S2 at +22, S3 at +50 and S4 at +60 minutes relative to stressor onset), stored on ice, frozen at -20 °C and analysed in duplicate by ELISA (Demeditec DES6611). R-R intervals and ECG are recorded with a Polar H10 chest strap and analysed with Kubios HRV; blood pressure with an automatic Omron monitor; SpO2 with a finger pulse oximeter. Validated Spanish questionnaires: PSS-14, STAI-Trait, ASI-3 and MAIA-2 (online screening); STAI-6 and a visual analogue scale of stress (four times during the session); Karolinska Sleepiness Scale (end of session). Descriptive and control variables: age, sex, years of practice and personal best; menstrual cycle phase, sleep, caffeine and physical activity on the day of the session.

Statistical analysis. Cortisol will be log-transformed. Primary analysis: ANCOVA of log(S4) with group as factor and log(S1) and log(S2) as covariates. Complementary analysis: linear mixed model (group x time, S1-S4). Autonomic and subjective outcomes will be analysed in the same way, with Holm correction. Sensitivity analyses: stress responders only; adjustment for menstrual cycle phase and sex. Exploratory moderation analyses: trait anxiety, anxiety sensitivity, interoceptive awareness, chronic perceived stress and the cortisol response to the stressor. Effect sizes with 95% confidence intervals will be reported to inform the sample size of a confirmatory trial.

Sample size. As an exploratory trial, no formal power calculation is performed; following the recommendation of at least 12 participants per group for pilot studies (Julious, 2005), 28 participants (14 per group) will be enrolled to allow for losses.

Safety. Apnoeas are performed dry and lying down, which removes the risk of drowning and falls. Heart rate and SpO2 are monitored continuously and the apnoea is stopped if SpO2 falls below 85% or any symptom appears. Participants may remove the hand from the cold water at any time. A written syncope protocol is in place and a defibrillator is available at the faculty.

Tipo de estudo

Intervencional

Inscrição (Estimado)

28

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

  • Nome: Francisco de Asís Fernández Martínez, PhD
  • Número de telefone: +34 91 665 50 60
  • E-mail: fasis.fernandez@urjc.es

Locais de estudo

    • Madrid
      • Alcorcón, Madrid, Espanha, 28922
        • Universidad Rey Juan Carlos, Faculty of Health Sciences, Alcorcón Campus
        • Contato:
          • Francisco de Asís Fernández Martínez, PhD
          • Número de telefone: +34 91 665 50 60
          • E-mail: fasis.fernandez@urjc.es
        • Investigador principal:
          • Francisco de Asís Fernández Martínez, PhD

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Age 18 years or older
  • Current breath-hold diving (apnoea) federation licence with insurance
  • Personal best in dry static apnoea of at least 2 minutes

Exclusion Criteria:

  • Cardiovascular, respiratory or endocrine disease, or hypertension
  • Contraindication to cold exposure (e.g., Raynaud's phenomenon)
  • Use of corticosteroids, beta-blockers or psychotropic drugs
  • Smoking
  • Pregnancy
  • Use of hormonal contraceptives
  • Periodontal disease
  • Shift work
  • Previous experience with laboratory stressors

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Ciência básica
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Dry static apnoea

Participants complete the Maastricht Acute Stress Test and then perform a 24-minute dry static apnoea session, followed by supine rest until 60 minutes after stressor onset.

Four dry static apnoeas in the supine position, each lasting 50% of the participant's personal best (maximum 3 minutes), in 5-minute cycles with at least 2 minutes of free breathing between apnoeas. Hyperventilation and lung packing are not allowed. Continuous supervision by an investigator trained in apnoea and first aid, with heart rate and SpO2 monitoring; the apnoea is stopped if SpO2 falls below 85% or any symptom appears.

Standardized laboratory stressor: 5 minutes of instructions followed by 10 minutes alternating periods of 45-90 seconds with one hand immersed in water at about 2 °C with periods of mental arithmetic aloud with negative feedback. Participants can remove the hand at any time. Debriefing at the end of the session.

Outros nomes:
  • MAST
Outro: Passive rest

Participants complete the Maastricht Acute Stress Test and then rest for 24 minutes listening to a neutral audio (time-matched control), followed by supine rest until 60 minutes after stressor onset.

Standardized laboratory stressor: 5 minutes of instructions followed by 10 minutes alternating periods of 45-90 seconds with one hand immersed in water at about 2 °C with periods of mental arithmetic aloud with negative feedback. Participants can remove the hand at any time. Debriefing at the end of the session.

Outros nomes:
  • MAST

Supine rest listening through headphones to a neutral informative audio, previously validated as emotionally neutral with the Self-Assessment Manikin. No breathing instructions are given.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Prazo
Salivary cortisol 60 minutes after stressor onset (S4)
Prazo: 60 minutes after the start of the stressor (S4), within the single experimental session; samples at 7 minutes before (S1) and 22 minutes after (S2) stressor onset are used as covariates
60 minutes after the start of the stressor (S4), within the single experimental session; samples at 7 minutes before (S1) and 22 minutes after (S2) stressor onset are used as covariates

Medidas de resultados secundários

Medida de resultado
Prazo
Salivary cortisol across the session
Prazo: 7 minutes before (S1) and 22 (S2), 50 (S3) and 60 (S4) minutes after stressor onset, within the single experimental session
7 minutes before (S1) and 22 (S2), 50 (S3) and 60 (S4) minutes after stressor onset, within the single experimental session
Heart rate
Prazo: Baseline rest, stressor, 24-minute intervention period and recovery up to 60 minutes after stressor onset, within the single experimental session
Baseline rest, stressor, 24-minute intervention period and recovery up to 60 minutes after stressor onset, within the single experimental session
Heart rate variability (RMSSD)
Prazo: Baseline rest, stressor, 24-minute intervention period and recovery up to 60 minutes after stressor onset, within the single experimental session
Baseline rest, stressor, 24-minute intervention period and recovery up to 60 minutes after stressor onset, within the single experimental session
Systolic and diastolic blood pressure
Prazo: Three measurements during the single experimental session: baseline, after the stressor and at the end of the session (60 minutes after stressor onset)
Three measurements during the single experimental session: baseline, after the stressor and at the end of the session (60 minutes after stressor onset)
State anxiety (STAI-6)
Prazo: Four time points during the single experimental session: baseline, after the stressor, after the intervention period and at the end of the session
Four time points during the single experimental session: baseline, after the stressor, after the intervention period and at the end of the session
Perceived stress (visual analogue scale)
Prazo: Four time points during the single experimental session: baseline, after the stressor, after the intervention period and at the end of the session
Four time points during the single experimental session: baseline, after the stressor, after the intervention period and at the end of the session
Minimum peripheral oxygen saturation during apnoeas (apnoea group only)
Prazo: During each of the 4 apnoeas of the 24-minute intervention period
During each of the 4 apnoeas of the 24-minute intervention period
Minimum heart rate during apnoeas (apnoea group only)
Prazo: During each of the 4 apnoeas of the 24-minute intervention period
During each of the 4 apnoeas of the 24-minute intervention period

Outras medidas de resultado

Medida de resultado
Prazo
Sleepiness (Karolinska Sleepiness Scale)
Prazo: End of the single experimental session (60 minutes after stressor onset)
End of the single experimental session (60 minutes after stressor onset)
Number of participants with adverse events
Prazo: From the start to the end of the single experimental session (about 85 minutes)
From the start to the end of the single experimental session (about 85 minutes)

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Francisco de Asís Fernández Martínez, PhD, Universidad Rey Juan Carlos

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

11 de janeiro de 2027

Conclusão Primária (Estimado)

30 de abril de 2027

Conclusão do estudo (Estimado)

31 de maio de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

16 de novembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

16 de novembro de 2026

Primeira postagem (Real)

20 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

20 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

16 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever